FDA approves Abbott Labs (ABT) for a new, expanded indication to its leading MitraClip™ device used to repair a leaky mitral valve without open-heart surgery. This stock is starting to look good.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.